Company intelligence / Profile preview
Inhalon Biopharma
Carrboro, North Carolina, United Statesinhalon.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Inhalon has completed IND-enabling studies and a landmark Phase 1b study showing that inhaled antibodies achieve much higher concentrations throughout the respiratory tract compared to IV delivery, with no drug-related adverse events. The lead program IN‑002 is advancing into a human challenge Phase 2a trial for RSV in partnership with hVIVO. Preclinical data show rapid viral clearance and strong safety profile. Other pipeline candidates are at preclinical or IND-enabling stages.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Monoclonal antibodies (mAbs)Inhaled immunotherapies
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →03
Partnerships
hVIVO (contract research organization conducting the upcoming human challenge trial for RSV candidate)
Beyond the preview
Go deeper on Inhalon Biopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Inhalon Biopharma.